P21 and p27: roles in carcinogenesis and drug resistance

Abde M Abukhdeir1, Ben Ho Park

  • 1The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Breast Cancer Research Program, Baltimore, MD, USA.

Insights

This review examines cyclin-dependent kinase inhibitors p21 and p27, crucial for cell cycle regulation. Their loss is linked to cancer and drug resistance, though they can paradoxically promote tumors.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Human cancers result from dysregulated cell growth and death, governed by cell cycle proteins.
  • Cyclins, cyclin-dependent kinases (CDKs), and CDK inhibitors are key regulators of the cell cycle.
  • Loss of G1-checkpoint CDK inhibitors p21 (CDKN1A) and p27 (CDKN1B) is implicated in human malignancies.

Purpose of the Study:

  • To review the identification and function of p21 and p27.
  • To explore the roles of p21 and p27 in carcinogenesis.
  • To analyze the involvement of p21 and p27 in drug resistance.

Main Methods:

  • Literature review of historic and recent studies.
  • Analysis of protein identification and function.
  • Examination of roles in cancer development and drug resistance.

Main Results:

  • Loss of p21 and p27 function is linked to cancer development and progression.
  • Functional loss of p21 and p27 may confer a drug-resistance phenotype.
  • Paradoxical evidence suggests p21 and p27 can also promote tumor growth.

Conclusions:

  • p21 and p27 are critical regulators with complex roles in cell cycle control.
  • Their dysregulation contributes to human carcinogenesis and impacts therapeutic outcomes.
  • Understanding these dual roles is vital for cancer treatment strategies.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...